Table 4.

Odds of colorectal cancer patients with cancer being resected with curative intent, odds of patients with Dukes’ B or C colon cancer being treated with chemotherapy and odds of Dukes’ stage A–C rectal cancer being treated with radiotherapy: by region, age, cancer site or sex

	Resection for curative intent				Colon Dukes’ B*				Colon Dukes’ C*				Rectum Dukes' A–C*
	N	OR	95%CI		N	OR	95%CI		N	OR	95%CI		N	OR	95%CI
Region†
Northern Europe	385	0.88	0.71	1.09	110	0.29	0.15	0.56	50	0.88	0.46	1.69	118	0.58	0.38	0.89
Western Europe	2092	1.62	1.43	1.85	591	0.10	0.06	0.16	346	0.64	0.48	0.87	411	1.22	0.95	1.56
Southern Europe‡	2912	1.00			736	1.00			529	1.00			797	1.00
Eastern Europe	1195	0.46	0.41	0.52	259	0.89	0.64	1.23	154	0.89	0.61	1.32	480	0.46	0.36	0.59
USA	2832	1.72	1.52	1.94	727	1.25	0.97	1.60	913	1.56	1.23	1.98	484	1.39	1.10	1.76
Age (years)
15–64	3194	1.00			674	1.00			684	1.00			890	1.00
65–74	3195	0.89	0.79	0.99	797	0.61	0.48	0.77	653	0.47	0.37	0.59	784	0.69	0.57	0.84
75–99	3027	0.48	0.43	0.53	952	0.07	0.05	0.10	655	0.10	0.08	0.13	616	0.30	0.24	0.38
Site
Colon	6191	1.00
Rectum	3225	0.73	0.66	0.79
Sex
Male													1324	1.00
Female													966	0.92	0.77	1.10

*Dukes’ stage A–D correspond to TNM stage categories I–IV.

†Northern Europe: Finland; Western Europe: France (Côte d'Or) and the Netherlands (North East Netherlands); Southern Europe: Italy (Genova, Ragusa and Varese), Slovenia and Spain (Granada, Navarra and Tarragona); Eastern Europe: Estonia, Poland (Cracow and Kielce) and Slovakia.

‡Data for Ragusa (424) are not included in the percentages of Dukes’ stage for Southern Europe